Percutaneous Sheath Introducers Market

The market for Percutaneous Sheath Introducers was estimated at $1.2 billion in 2025; it is anticipated to increase to $1.6 billion by 2030, with projections indicating growth to around $2.3 billion by 2035.

Report ID:DS1801117

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Percutaneous Sheath Introducers

Customization Available

Percutaneous Sheath Introducers - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Percutaneous Sheath Introducers Market Outlook

Revenue, 2025

$1.2B

Forecast, 2035

$2.3B

CAGR, 2026 - 2035

6.9%

The Percutaneous Sheath Introducers industry revenue is expected to be around $1.2 billion in 2026 and expected to showcase growth with 6.9% CAGR between 2026 and 2035. The increasing importance of the sheath introducer is underlined by its role in minimally invasive vascular procedures and catheter treatments. Their essential function in medical interventions is becoming more apparent. The increasing numbers of cardiology procedures and the growth in structural heart treatments and endovascular interventions are driving up the need for medical equipment. This is particularly true in locations which have elderly populations with cardiovascular disease. In a large number of healthcare facilities, sheath introducers used by radiologists and cardiologists are used in nearly 80% of all medical procedures. This is evidence that these introducers greatly aid in the execution of catheter procedures. The valved sheath valve mechanisms were the market leaders in percutaneous sheath introducers in 2025 with sales of around $0.75 billion. This can be attributed to the priority given by clinicians to the valved sheath introducers for reduced blood loss, reliability in haemostasis and streamlined workflow during procedures that involve the radial and femoral access.

Clinical relevance is being reinforced by the integration of these introducers with vascular closure and imaging guidance systems as well as through developments including atraumatic tips and improved kink resistance. Specialised vascular introducer sheaths are used for vascular access in cardiology and radiology interventions. They create a continuous passageway for catheters, wires and other diagnostic and therapeutic equipment to be passed through during interventional radiology and cardiology procedures. Characteristics comprise a low profile introducer needle, dilator, a radiopaque dilator with a hydrophilic coating and a high performance valve to provide hemostasis and also facilitate procedural efficiency. The medical devices in question are used in procedures such as coronary and peripheral angioplasty and electrophysiology. They are also used in procedures such as ablation and structural heart interventions. Furthermore they are used in neurovascular and oncology treatments which involve embolization. They are crucial in numerous complex endovascular procedures which require secure access to the blood vessels. Market demand is driving the development of catheters that can be used once and then discarded, smaller French sizes, better compatibility with radial access procedures and improved operator comfort, all of which are part of a trend towards minimally invasive procedures.

Percutaneous Sheath Introducers market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Percutaneous Sheath Introducers Market Outlook

Market Key Insights

The Percutaneous Sheath Introducers market is projected to grow from $1.2 billion in 2025 to $2.3 billion in 2035. This represents a CAGR of 6.9%, reflecting rising demand across Catheter Insertion, Vascular Access in Dialysis, and Drug Delivery Systems.
This market is dominated by prominent players such as Boston Scientific Corporation, Medtronic PLC and Terumo Corporation, as a result shaping the competitive market landscape.
The U.S. and Germany together are predicted to be the largest markets for percutaneous sheath introducers. They are anticipated to grow at a rate of 4.5 6.6% during the period 2025 to 2030.
Markets which are emerging including India, South Korea and Brazil are expected to grow most strongly at a compound annual growth rate between 7.9% and 9.5%.
The trend towards minimally invasive treatments is becoming increasingly significant in the US and German medical industries. This trend is likely to add $48 million to the revenue of percutaneous sheath introducers by 2030.
Between 2025 and 2035 the market for percutaneous sheath introducers is predicted to increase by $1.1 billion. In this period Interventional Radiology & Neurovascular Application will see manufacturers competing to gain the largest market share.
With
rise in cardiovascular diseases, and
Technological Advancements, Percutaneous Sheath Introducers market to expand 95% between 2025 and 2035.

Percutaneous Sheath Introducers - Country Share Analysis

Opportunities in the Percutaneous Sheath Introducers

Across Western Europe, several percutaneous access centres and vascular clinics use radial access for electrophysiology and more complicated cerebral blood vessel work; despite this, a number still employ older non valved sheath introducers. The non valved sheath revenue will grow globally to $0.53 billion in 2030, from 2025. The predicted compound annual growth rate for this increase is also 5.17%.This growth will come from 2025 levels of $0.41 billion. By 2030, the growth is expected to be $0.53 billion. Companies which manufacture low profile non valved batteries that are suited to same day discharge can gain more market share by linking up with private hospitals which have computerised systems and regional purchasing groups.

Growth Opportunities in North America and Asia-Pacific

North American demand for sheath introducers is being driven by the interventional cardiology devices sector, which accounts for the majority of these products in the region. This sector has seen increasing usage of its products in complex PCI, structural heart interventions and radial access systems. There are opportunities in devices such as ultra low profile introducers, introducers with hydrophilic coatings and devices which have been optimised for hemostasis. In this highly competitive environment, companies that already supply medical equipment to hospitals are fighting to retain their contracts. Meanwhile, a number of other companies are seeking to supply outpatient facilities such as those offering cardiac catheter procedures and also surgical centres. As a result, suppliers to the medical sector must increase the efficiency of their clients work flows, reduce the time patients spend under radiation and integrate their systems with other, more advanced, medical equipment used in cardiac cath labs. The region has several key factors which are driving the demand for such devices. These drivers are the very high incidence of cardiovascular disease in the region, the reimbursement policies of the country which offer payment for patients who undergo such a procedure on the same day as their operation, the trend towards discharge from hospital on the same day as a procedure and the efforts of clinicians to reduce the risk of the procedure failing. Hospitals and integrated delivery networks should be prioritised as business partners, with a value proposition that is evidence based. The company should also expand its product lines to include procedures specific to interventional radiology and neurovascular treatments in order to increase its share of hospital budgets.

Asia Pacific's demand for percutaneous sheath introducers is being driven by a rapid rise in cardiology procedures. However, a new market is emerging from the interventional radiology and neurovascular fields, as stroke treatment networks develop and endovascular techniques improve. This has opened up the potential for the use of multi purpose sheath introducers. In the vascular access arena, both international and local companies are vying for market share, with both competing on price and their ability to tailor their products to the needs of a specific region. To maintain their market position, products which are tailored to local needs are vital. A growth driver in the region is the development of new hospitals to cater for the increasing medical needs. Public funds have been invested into cardiac catheter labs and neurological centres, as well as peoples rising incomes and their demand for advanced medical care. Additionally, the tourism industry for medical care in the region has grown. This has helped to increase the number of procedures taking place in the region in coronary, the peripheral and neurological region's. Companies which are successful have used tiered product portfolios in conjunction with premium and value segments, local assembly in order to meet local price and regulatory requirements and to supply comprehensive training to doctors. This training increases physician loyalty to specific products which are used in cardiology, interventional radiology and neurovascular departments.

Market Dynamics and Supply Chain

Driver: Growing Prevalence of Cardiovascular Diseases and Expansion of Minimally Invasive Procedures Worldwide

The rising prevalence of cardiovascular diseases (CVDs) and the expansion of minimally invasive interventions are also major drivers for the percutaneous sheath introducers market. Globally, the burden of CVDs including coronary artery disease, peripheral artery disease, and stroke continues to increase due to aging populations, sedentary lifestyles, and metabolic disorders. This also drives demand for diagnostic and interventional catheterization procedures where percutaneous sheath introducers are also essential for secure vascular access. Sheaths with hydrophilic coatings and varied French sizes facilitate smooth guidewire navigation, reducing vessel trauma and improving patient comfort, supporting higher procedural volumes. Concurrently, there is also significant growth in minimally invasive procedures such as percutaneous coronary intervention, endovascular aneurysm repair, and neurovascular interventions. These approaches reduce recovery times, hospital stays, and complication risks compared to open surgery, making them highly preferred by clinicians and patients. Percutaneous sheath introducers are also vital to these techniques, enabling efficient catheter delivery and exchange. Together, rising CVD incidence and the shift toward minimally invasive modalities are also expanding clinical adoption of sheath introducers across hospitals and specialty care centers globally.

A key driver in the percutaneous sheath introducers market is also the advancement in sheath materials, design, and surface coating technologies. Innovations such as hydrophilic and polymer‑coated introducers reduce friction during insertion, lower the risk of vessel trauma, and enhance procedural efficiency. Improved biocompatible materials also decrease inflammatory responses and patient discomfort. These technological improvements attract clinicians seeking reliable performance and better patient outcomes, supporting broader adoption in interventional cardiology, radiology, dialysis access, and drug delivery applications.

Restraint: Risk of Complications and Preference for Alternative Vascular Access Techniques Hinders Adoption Rates

Concerns around procedure‑related complications such as bleeding, arterial damage, or infection act as restraints on sheath introducer use. Clinicians in some specialties increasingly adopt alternative vascular access methods or devices that reduce sheath dependency, such as radial access or micro‑catheter systems. These preferences shift demand away from traditional introducers, impacting overall market volume. Reduced utilization in specific procedures diminishes recurring demand and influences procurement strategies in interventional suites.

Opportunity: Growing complex interventional cardiology and structural heart procedures in Asia-Pacific tertiary care hospitals and Rising peripheral vascular disease treatments in Latin American public hospitals seeking affordable access

The percutaneous sheath introducer with a valve built in will be the region of greatest growth in interventional cardiology in the Asia Pacific region. This is because the region has rapidly expanding structural heart programmes and interventional cardiology facilities. Between 2026 and 2030, the compound annual growth rate of the global valve sheath market is predicted to be 7.8%. The value of the global valve sheath market will rise from $0.75 billion in 2025 to $1.09 billion by 2030. Healthcare professionals in India, China and other parts of South eastern Asia are seeking better methods of haemostasis and large bore access. These premium vascular access devices which are valved and have smaller profiles are however still not only sufficiently represented; collaboration with manufacturers and targeted training would be beneficial.

Percutaneous transluminal angioplasties are not only used widely enough in public hospitals outside the main cities of Latin America to treat diabetes and disease affecting the arteries. The relatively low penetration rate in interventional markets provides opportunities for customised, cost effective collections of products that are either valved or unvalved and which are used in the treatment of the vascular systems peripheral parts. Vascular access devices which are more reliable are increasingly demanded by hospitals as a result of these factors- the time taken for the procedure being reduced and complications occurring less frequently. Establishing partnerships with government run tenders, local distributors and training associations can hasten market entry and also increase growth in regional region's and smaller towns.

Challenge: High Costs of Advanced Sheath Introducers and Reimbursement Limitations Constrain Market Growth

The premium pricing of technologically advanced percutaneous sheath introducers coupled with limited reimbursement policies restricts adoption, especially in price‑sensitive regions. Sheaths with hydrophilic coatings and specialty materials command higher costs compared to basic models, deterring purchase by smaller clinics or budget‑constrained hospitals. Inadequate reimbursement for interventional procedures further discourages investment in premium introducers, leading facilities to select lower‑cost alternatives. This dynamic slows revenue growth for manufacturers and limits market penetration in emerging healthcare systems.

Supply Chain Landscape

Vascular Access Materials

Becton Dickinson and CompanyTerumo Corporation

Percutaneous Sheath Introducers

Boston Scientific CorporationMedtronic PLCTerumo Corporation

Device Distribution Channels

Boston Scientific CorporationTeleflex IncorporatedMedtronic PLC

Interventional Cardiology End-users

HospitalsAmbulatory Surgical CentersCardiac Catheterization Labs

Vascular Access Materials

Becton Dickinson and CompanyTerumo Corporation

Percutaneous Sheath Introducers

Boston Scientific CorporationMedtronic PLCTerumo Corporation

Device Distribution Channels

Boston Scientific CorporationTeleflex IncorporatedMedtronic PLC

Interventional Cardiology End-users

HospitalsAmbulatory Surgical CentersCardiac Catheterization Labs

Percutaneous Sheath Introducers - Supply Chain

Use Cases of Percutaneous Sheath Introducers in Catheter Insertion & Vascular Access in Dialysis

Catheter Insertion : In catheter insertion procedures, percutaneous sheath introducers are used to establish and maintain secure vascular access for diagnostic and interventional catheter placement. Sheaths with hydrophilic coatings and varying French sizes improve ease of insertion and reduce vascular trauma. These devices support smooth guidewire and catheter exchanges, enhancing procedural efficiency and patient comfort. Leading players such as Teleflex, Cook Medical, BD (Becton Dickinson), and Terumo are widely chosen for their advanced sheath designs, reliable performance, and robust global distribution. Their strengths lie in offering comprehensive portfolios with different sizes and configurations that meet diverse clinical needs in cardiology and interventional radiology.

Vascular Access in Dialysis : For vascular access in dialysis, percutaneous sheath introducers facilitate the insertion and maintenance of hemodialysis catheters into central veins, enabling efficient blood flow for routine treatments. Sheaths with reinforced walls and smooth introducer tips help minimize vessel damage and infection risk during repeated access. Manufacturers like Teleflex, AngioDynamics, Cook Medical, and B. Braun support the dialysis segment with durable and sterile sheath systems. These companies emphasize safety, ease of use, and compatibility with a range of catheter sizes, addressing the high procedural volumes in chronic kidney disease care.

Drug Delivery Systems : In drug delivery systems, percutaneous sheath introducers create stable portals for infusion catheters used in targeted chemotherapy, pain management, or localized therapeutic delivery. Sheaths designed for precision and reduced blood loss allow clinicians to deliver medications directly into specific vascular territories with minimal disruption. Top market providers such as Teleflex, Cardinal Health, BD, and Terumo offer introducer systems that combine ergonomic design, biocompatible materials, and secure sealing mechanisms. Their products enhance procedural control and reliability, making them preferred choices in oncology, anesthesia, and chronic pain clinics where accurate drug administration is critical.

Recent Developments

Recent developments in the percutaneous sheath introducers market highlight a strong focus on innovations in sheath design, hydrophilic coatings, and integrated access systems that improve vascular access and catheter insertion outcomes. Manufacturers are emphasizing biocompatible materials, friction‑reducing surfaces, and customized French sizes, which enhance procedural efficiency and patient comfort. A key market trend is the adoption of sheath introducer kits that are pre‑assembled with guidewires and dilators, simplifying workflows in interventional cardiology, radiology, and dialysis access procedures and expanding clinical utilization.

June 2024 : Terumo Corporation launched a new hydrophilic‑coated introducer sheath that reduces vascular resistance and enhances ease of insertion, reflecting ongoing material and design innovation in vascular access technology.

March 2024 : Boston Scientific Corporation announced a sport of its new introducer sheath with enhanced navigation capabilities for complex interventional procedures, supporting improved placement accuracy.

Impact of Industry Transitions on the Percutaneous Sheath Introducers Market

As a core segment of the Medical Device industry, the Percutaneous Sheath Introducers market develops in line with broader industry shifts. Over recent years, transitions such as Shift towards Minimally Invasive Procedures and Implementation of Advanced Materials and Coating Technologies have redefined priorities across the Medical Device sector, influencing how the Percutaneous Sheath Introducers market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Shift towards Minimally Invasive Procedures

The trend towards minimally invasive treatments is leading to rapid expansion of the market for percutaneous sheath introducers, especially for cardiology and vascular access applications. The US and Germany are pioneering countries in the shift towards the standardised use of catheter based technology to treat cardiovascular disease. Industry revenue from this region is predicted to rise by $48 million by the year 2030. This increase in revenue will be felt across all aspects of the industry from manufacturing and procurement to the actual delivery of the treatment. The companies that are prioritizing smaller profile, haemostasis optimised introducers which can be used for radial and femoral access are well placed to take advantage of this added revenue. This is because there is a growing need for devices which reduce procedure times, cut down the incidence of complications and increase the number of patients treated in hospitals where resources are limited.

Implementation of Advanced Materials and Coating Technologies

The percutaneous sheath introducers market is undergoing a transformation driven by the adoption of advanced materials and surface coating technologies. Modern sheaths now feature hydrophilic coatings, polymer linings, and biocompatible materials that reduce friction, minimize vessel trauma, and improve patient comfort during procedures. This transition has influenced interventional cardiology, radiology, and dialysis industries, enabling faster catheter exchanges, shorter procedure times, and fewer complications. Hospitals and specialty clinics are increasingly replacing conventional metal or basic polymer sheaths with these technologically enhanced introducers. Additionally, manufacturers are collaborating with device developers to integrate sheaths with catheter systems, streamlining workflows and enhancing procedural precision. These innovations are driving demand for high-performance introducers, encouraging R&D investments, and reshaping the competitive landscape across global healthcare markets.